DataClue.io
Pharmaceutical Research and Development for Discovering New Drug Opportunities
Company Overview
Snapshot
Founded in February 2019 by Osnat Ben Nesher Zaretsky, Maytal Bivas-Benita, and Tanya Yankelevich, DataClue.io operated with 1–10 employees. The company ceased operations in November 2021.
Business overview
DataClue.io is a digital health startup focused on pharmaceutical and biomedical drug research and development. The company aims to assist large pharmaceutical firms in identifying new drug opportunities by leveraging their data, accelerating time to market, and fostering internal and external collaboration in clinical research and drug development. DataClue.io seeks to achieve these objectives through clinical trial cross-analysis and by managing rights for collaborating parties, operating within the Health Tech & Life Sciences sector, specifically in Digital Healthcare and Medical Decision Support.
Log in to access full profile ›Company Intelligence Q&A
- What is DataClue.io's primary focus?
- DataClue.io is primarily focused on pharmaceutical and biomedical drug research and development within the digital health space.
- When was DataClue.io founded?
- DataClue.io was founded in February 2019.
- Who are the founders of DataClue.io?
- The co-founders of DataClue.io are Osnat Ben Nesher Zaretsky, Maytal Bivas-Benita, and Tanya Yankelevich.
- What is the operational status of DataClue.io?
- DataClue.io is non-active and ceased to operate in November 2021.
- Which markets did DataClue.io target?
- DataClue.io targeted geomarkets including Switzerland, Europe, the United States, and the United Kingdom.